Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles

International Journal of Biological Macromolecules

Volumn 49, Issue 3, 2011, Pages 390-396

  Sarmah, Jayanta K ^a   Mahanta, Rita ^b   Bhattacharjee, Saibal Kanti ^a   Mahanta, Ranadeep ^c   Biswas, Angshuman ^d  

^a GAUHATI UNIVERSITY   (India)

^b Department of Molecular Biology and Biotechnology   (India)

^c GAUHATI MEDICAL COLLEGE   (India)

^d Central Drugs Laboratory India   (India)

Author keywords

Breast cancer; Kinetic models; Natural polysaccharide; Polymer cross linking; SEM; TEM

Indexed keywords

GLUTARALDEHYDE; GUAR GUM; NANOPARTICLE; POLYMER; TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG TISSUE LEVEL; DRUG UPTAKE; EMULSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MORPHOLOGY; MOUSE; NANOENCAPSULATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TABLET FORMULATION; TRANSMISSION ELECTRON MICROSCOPY;

CYAMOPSIS TETRAGONOLOBA; MUS;

EID: 79959585871     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2011.05.020     Document Type: Article

References (37)

1. Sujja-areevath J., Munday D.L., Cox P.J., Khan K.A. Eur. J. Pharm. Sci. 1998, 6:207-217.
2. Fessi H., Marty J.-P., Puisieux F., Carstensen J.T. J. Pharm. Sci. 1982, 71:749-752.
3. Duru C., Colombo P., Gaudy D., Massimo G., Barthelemy P., et al. Pharma. Technol. Int. 1992, 4:15-23.
4. Baweja J.M., Misra A.N. Pharmazie 1997, 52:856-859.
5. Khullar P., Khar R.K., Agarwal S.P. Indian J. Pharm. Sci. 1999, 61:342-345.
6. Al- Saidan S.M., Krishnaiah Y.S.R., Satyanarayana V., Bhaskar P., Karthikeyan R.S. Eur. J. Pharm. Biopharm. 2004, 58:697-703.
7. Misra A.N., Baweja J.M. Indian Drugs 1997, 34:216-223.
8. Labhasetwar V., Song C., Humphrey W., Shebuski R. J. Pharm. Sci. 1998, 87:1229.
9. Chowdhury S., Ellis P.A. J. Br. Menopause Soc. 2005, 11. 96Y102.
10. O'Regan R.M., Jordan V.C. Lancet Oncol. 2002, 3:207-214.
11. Bonneterre J., Thurlimann B., Robertson J.F.R., Krzakowski M., Mauriac L., Koralewski P., et al. J. Clin. Oncol. 2000, 18:3748-3757.
12. Cameron D.A., Ritchie A.A., Langdon S., Anderson T.J., Miller W.R. Breast Cancer Res. Treat. 1997, 45:99-107.
13. Osborne C.K. N. Engl. J. Med. 1998, 339:1609-1618.
14. Ravdin P.M., Green S., Dorr T.M., McGuire W.L., Fabian C., Pugh R.P., et al. J. Clin. Oncol. 1992, 10:1284-1291.
15. de Lima G.R., Facina G., Shida J.Y., Chein M.B.C., Tanaka P., Dardes R.C., et al. Eur. J. Cancer 2003, 39:891-898.
16. Maillard S., Amelier T., Gauduchon J., Gougelet A., Gouilleux F., Legrand P., Marsaud V., Fattal E., Sola B., Renoir J.-M. J. Steroid Biochem. Mol. Biol. 2005, 94:111-121.
17. McVie J.G., Simonetti G.P., Stevenson D., Brigss R.J., Guelen P.J., de Vos D. Methods Find. Exp. Clin. Pharmacol. 1986, 8:505-512.
18. Shin S.-C., Chol J.-S., Li X. Int. J. Pharm. 2006, 313:144-149.
19. Tukker J.J., Blankenstein M.A., Nortier J.W. J. Pharm. Pharmacol. 1986, 38:888-892.
20. Bonferoni M.C., Rossi S., Ferrari F., Stavik E., Pena-Romero A., Caramella C. AAPS PharmSciTech 2000, 1(2). (article 15).
21. Aguzzi C., Bonferoni M.C., Fortich M.R.O., Rossi S., Ferrari F., Caramella C. AAPS PharmSciTech 2002, 3(3). (article 27).
22. Díez-Peña E., Frutos P., Frutos G., Quijada-Garrido I., Barrales-Rienda J.M. AAPS PharmSciTech 2004, 5(2). (article 33).
23. Khullar P., Khar R.K., Agarwal S.P. Drug Dev. Ind. Pharm. 1998, 24:1095-1109.
24. Vinogradov S.V., et al. Adv. Drug Deliv. Rev. 2002, 54:135.
25. Krishnaiah Y.S.R., Karthikeyan R.S., Satyanarayana V. Int. J. Pharm. 2002, 241:353-366.
26. Krishnaiah Y.S.R., Karthikeyan R.S., Gouri Sankar V., Satyanarayana V. J. Control. Release 2002, 81:45-56.
27. Toti U.S., Aminabhavi T.M. J. Control. Release 2004, 95:567-577.
28. Soppirnath K.S., Aminabhavi T.M. Eur. J. Pharm. Biopharm. 2002, 53:87-98.
29. Wassel G.M., Omar S.M., Ammar N.M. J. Drug Res. 1989, 18:1-8.
30. Sarmah J.K., Bhattacharjee S.K., Mahanta R., Mahanta R. J. Inclusion Phenom. Macrocycl. Chem. 2009, 65(3-4):329-334.
31. Gohel M., Patel M., Amin A., Agrawal R., Dave R., Bariya N. AAPS PharmSciTech 2004, 5(3). (article 36).
32. Chaurasia M., Chaurasia M.K., Jain N.K., Jain A., Gupta Y., Jain S.K. AAPS PharmSciTech 2006, 7(3):74.
33. Coviello T., Alhaique F., Dorigo A., Matricardi P., Grassi M. Eur. J. Pharm. Biopharm. 2007, 66:200-209.
34. Korsmeyer R.W., Peppas A. Controlled Release Delivery Systems 1983, Marcel Dekker, New York, 77-90.
35. Peppas N.A., Khare Ar. Adv. Drug Del. Rev. 1993, 11:1-35.
36. Bamba M., Puisieusx F., Marty J.P., Carstensen J.T. Int. J. Pharm. 1979, 2:307-315.
37. Lee P.I. J. Control. Release 1985, 2:255.